Fact CheckerSign in

NCT04630574Completed

Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers

Source: ClinicalTrials.gov · Last updated 20 Feb 2024

Brief summary (registry, in English)

The study proposes to identify deviant speech dimensions in patients with HD at presymptomatic and declared stages of the disease, compared to healthy subjects, using the computerized MonPaGe speech protocol. This tool is based on a multidimensional and quantified assessment of voice and speech, by a set of targeted acoustic and perceptual criteria.

Status (registry)
Completed
Study type
Observational
Enrollment
150 (actual)
First submitted
1 Nov 2020
Start date
23 Feb 2021
Primary completion date
5 Feb 2024
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT04630574

What you commit to

  • Study type: Observational
  • Participants enrolled: 150
  • From 23 Feb 2021 to the primary completion date, 5 Feb 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Huntington's disease patients with severe dysarthria (BECD score\> 16), acoustic analysis not being possible on unintelligible speech

Other

  • patients placed under the protection of justice

Who the study is looking for

  • major patients
  • francophone patients
  • Huntington's disease carriers confirmed by molecular biological analysis
  • carriers of pre-symptomatic Huntington's disease: Total Motor Score of the Unified Huntington's Disease Rating Scale \<5
  • carriers of Huntington's disease at a declared stage: Total Motor Score of the Unified Huntington's Disease Rating Scale ≥ 5
  • followed in the Competence Center Huntington's disease Bordeaux Hospital or in the Reference Center Huntington's disease Henri Mondor Hospital of Créteil
  • affiliates or beneficiaries of a social security scheme
  • Finally, a free, informed and express consent of the patient must be collected.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Henri Mondor
Coordinator of this site? Confirm its status
CréteilFranceUnknown status
Centre Hospitalier Universitaire De Bordeaux
Coordinator of this site? Confirm its status
TalenceFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.